![[CCO] Certification Coaching Organization LLC](https://staging.cco.us/wp-content/uploads/2015/05/CCO-Logo-2015-d3-500px.png "[CCO] Certification Coaching Organization LLC"){kind=logo}
🔍 Definition
Complications of devices, implants, and grafts are adverse conditions that arise as a direct consequence of an internal prosthetic device, implant, or graft that was surgically placed or implanted. Under ICD-10-CM Official Guidelines Section I.C.19.g, these complications are classified in categories T82–T85 and encompass mechanical failures (breakage, displacement, leakage, obstruction, perforation), infections and inflammatory reactions, hemorrhage, fibrosis, pain, stenosis, thrombosis, and other device-related adverse effects.
Critically, these conditions are distinguished from:
- Complications of surgical/medical care (T80–T81, T88) — intraoperative complications, postprocedural hematomas, wound dehiscence
- Normal healing — expected postoperative recovery without a specific complication
- Complications of external prosthetic devices — classified elsewhere (e.g., fitting/adjustment of prosthetic limb)
The four major anatomic/functional groupings are: (1) T82 — cardiac and vascular prosthetic devices; (2) T83 — genitourinary prosthetic devices; (3) T84 — orthopedic prosthetic devices and implants; and (4) T85 — other internal prosthetic devices (neurological, ocular, breast, peritoneal, gastrointestinal). Seventh-character extension is required on all applicable codes: A = initial encounter, D = subsequent encounter, S = sequela. See CDC/NCHS ICD-10-CM tabular instructions.
The 7th character assignment reflects the encounter type, not the age of the device. A patient presenting for the first time for active treatment of a complication uses A (initial encounter) even if the device has been implanted for years. Subsequent follow-up care for the same complication uses D.
🗂️ Alternative Terminology
| Formal / ICD-10-CM Term | Colloquial / Clinical / Lay Terms |
|---|---|
| Mechanical complication of internal cardiac valve prosthesis (T82.0xxA) | Prosthetic heart valve failure, valve dysfunction, stuck prosthetic valve |
| Complication of cardiac electronic device (T82.1xxA) | Pacemaker malfunction, ICD lead failure, pulse generator problem, pacing lead displacement |
| Complication of coronary artery bypass graft (T82.2xxA) | CABG graft failure, bypass graft occlusion, re-stenosis of bypass graft |
| Mechanical complication of other vascular graft (T82.3xxA) | Aortic graft leak, dialysis graft failure, peripheral bypass graft occlusion, synthetic graft stenosis |
| Infection due to cardiac device/vascular graft (T82.6xxA, T82.7xxA) | Pacemaker pocket infection, device endocarditis, CIED infection, infected prosthetic graft |
| Periprosthetic joint infection — T84.5xxA (PJI) | Infected total hip, infected knee replacement, prosthetic joint infection, deep periprosthetic infection |
| Mechanical complication of prosthetic joint (T84.0xxA) | Hip replacement dislocation, loosening of knee implant, aseptic loosening, instability of joint prosthesis |
| Complication of internal fixation device (T84.1xx–T84.2xxA) | Broken hardware, loose screws/plates, retained hardware complication, hardware failure |
| Complication of orthopedic bone graft (T84.3xxA) | Bone graft failure, autograft/allograft non-union, graft resorption |
| Infection due to neurostimulator (T85.73xA) | Infected spinal cord stimulator, deep brain stimulator infection, infected nerve stimulator |
| Mechanical complication of ventricular shunt (T85.01xA) | VP shunt malfunction, blocked shunt, CSF shunt failure, hydrocephalus shunt failure |
| Complication of peritoneal dialysis catheter (T85.61xA) | PD catheter malfunction, peritoneal dialysis access complication |
| Complication of breast prosthesis/implant (T85.4xxA) | Ruptured breast implant, capsular contracture, breast implant leakage, BIA |
🩺 Signs & Symptoms
Clinical presentation varies widely by device type and complication category. Coders and CDI specialists should watch for these documented findings that signal a reportable complication:
Mechanical Complications
- Device dislocation, migration, or displacement (e.g., hip prosthesis dislocation, pacing lead migration)
- Device malposition, obstruction, or leakage (e.g., VP shunt obstruction, peritoneal catheter malfunction)
- Loosening, breakage, or perforation (e.g., aseptic loosening of hip/knee prosthesis)
- Reoperation or revision surgery prompted by device failure
- Abnormal imaging findings: radiolucent lines around prosthesis (loosening), discontinuity of hardware
Infectious Complications
- Fever, leukocytosis, elevated CRP/ESR, positive cultures (wound, blood, aspirate)
- Local warmth, erythema, swelling, drainage at or near device site
- Positive joint aspirate — elevated WBC count (>1,100/μL synovial WBC for PJI per AAOS PJI guidelines)
- MRSA/MSSA bacteremia with documented device as source
- Sinus tract communicating with prosthesis (pathognomonic of PJI)
- Pocket erosion or wound breakdown at pacemaker/ICD pocket site
Other Systemic/Local Complications
- Hemorrhage: unexpected bleeding at or around device site (T82.81x, T83.81x, T84.81x, T85.81x)
- Fibrosis: capsular contracture (breast implant), pericardial fibrosis (pacemaker), progressive hardening
- Pain: unexplained pain at prosthesis site, pain out of proportion to expected recovery
- Stenosis: decreasing graft flow, re-stenosis on imaging (T82.85x, T83.85x, T84.85x, T85.85x)
- Thrombosis: acute DVT from vascular graft, valve thrombosis causing hemodynamic instability (T82.86x, T85.86x)
Do NOT code a T-code complication based on signs and symptoms alone without physician documentation linking the complication to the device. Under Official Guideline I.C.19.g, the provider must establish a causal relationship between the device and the condition.
🧭 Differential Diagnosis
| Condition | Key Distinguishing Feature | Relevant Code(s) |
|---|---|---|
| Periprosthetic joint infection (PJI) | Confirmed by MSIS/AAOS criteria: positive culture, elevated synovial WBC, sinus tract to prosthesis | T84.5xxA + organism (B95.x–B97.x) |
| Aseptic loosening | Mechanical failure WITHOUT infection — negative cultures, normal inflammatory markers, radiolucent lines on imaging | T84.01xA–T84.09xA (specific joint) |
| Superficial surgical site infection (SSI) | Infection confined to skin/subcutaneous tissue above fascia; prosthesis NOT involved — key CDI distinction | T81.40xA–T81.49xA |
| Prosthetic valve endocarditis | Positive blood cultures + echocardiographic evidence of valve vegetation | T82.6xxA or T82.7xxA + I33.0 or I39.x + organism |
| Cardiac device infection / CIED infection | Infection involving lead, generator pocket, or cardiac implantable electronic device | T82.7xxA + organism; distinguish from lead vegetation (endocarditis) |
| Postprocedural seroma / hematoma | Fluid collection without infection — documented as expected postop finding vs. complication | T81.30x–T81.33x (postprocedural hematoma); T82.81x if device hemorrhage |
| Adverse effect vs. complication | Complication = device malfunction/infection. Adverse effect = correct device, correct use, unexpected body reaction | T-code + external cause |
| Native joint/tissue disease vs. prosthesis complication | Distinguishes recurrent or new OA/inflammatory arthritis from prosthesis-related pathology | M16.x–M17.x (OA) vs. T84.0xxA (prosthesis complication) |
| Wound dehiscence without infection | No culture-positive infection; wound opening at surgical site | T81.30x postprocedural wound disruption |
📋 Clinical Indicators for Coders/CDI
| Clinical Indicator | Documentation Required | Coding Impact |
|---|---|---|
| Device/implant as the source | Provider must document that the complication is caused by or related to the device, implant, or graft | Required to assign T82–T85 code; without linkage, only symptom codes |
| Mechanical vs. infectious etiology | Document whether complication is mechanical (displacement, loosening, breakage) or infectious — impacts code and DRG | Mechanical → T84.0x; Infectious → T84.5x + organism; different MS-DRG assignment |
| Causative organism — MRSA vs. MSSA vs. other | Culture results, antibiotic susceptibility; document organism (e.g., "PJI due to MRSA") | B95.62 (MRSA), B95.61 (MSSA), B96.5 (Pseudomonas), B96.20 (E. coli) — affects RAF and HCC |
| POA (Present on Admission) status | Was the complication present at admission or did it develop during the hospital stay? | POA = N (No) → Hospital-Acquired Condition (HAC), may affect reimbursement and quality metrics |
| Sepsis due to device infection | Provider documents sepsis caused by device infection — "sepsis due to infected hip prosthesis" | Requires A41.x (specific sepsis) + T84.5xxA + organism; R65.20/21 for severe sepsis |
| Laterality for orthopedic joints | Right vs. left hip/knee/shoulder — required for T84.0xx codes with laterality extensions | Incorrect laterality = claim edit; right hip = T84.011xA (dislocation), T84.531xA (infection) |
| Revision vs. removal vs. replacement | What surgical procedure was performed? Revision of component? Complete removal? One-stage vs. two-stage exchange? | Drives CPT code selection (27134, 27137, 27138 for hip; 27487 for knee) |
| Specific joint components involved | Acetabular component, femoral stem, modular head — for implant registry and CPT accuracy | CPT codes differ by component; documentation supports medical necessity |
| Graft type for vascular complications | Autologous, synthetic, or biological graft; vessel location (coronary, aortic, peripheral) | T82.2xx (coronary), T82.3xx (other vascular) — different code families |
| Neurostimulator location | Spinal cord vs. peripheral nerve vs. deep brain stimulator — specific 4th character | T85.11x (electrode), T85.12x (pulse generator), T85.73x (infection) — location-specific |
When documentation refers to "infected hip replacement" or "infected knee," query the orthopedic surgeon to distinguish between: (1) Periprosthetic joint infection (deep, involving the prosthesis — T84.5xxA), (2) Superficial SSI (skin/subcutaneous only — T81.4xxA), or (3) Periprosthetic soft tissue infection without prosthesis involvement. This distinction carries major DRG and HCC weight differences.
🦴 Anatomy & Pathophysiology
Understanding the anatomic relationships for each device class informs correct code assignment:
Cardiac and Vascular Prosthetic Devices (T82)
Prosthetic heart valves (mechanical or bioprosthetic) are implanted to replace native valves affected by stenosis or regurgitation. Mechanical complications include leaflet obstruction (often due to pannus ingrowth or thrombus), structural valve deterioration (SVD) in bioprostheses, and paravalvular leak. Cardiac electronic devices (pacemakers, ICDs, CRT devices) consist of a pulse generator and intracardiac leads. Lead dislodgement occurs most commonly in the first 4–6 weeks post-implantation. CABG grafts (saphenous vein, internal mammary artery) are susceptible to early thrombosis and late atherosclerotic disease. Vascular grafts (aortic, peripheral, dialysis access) may develop stenosis, thrombosis, infection, or anastomotic pseudoaneurysm. According to American Heart Association device guidance, infection involving the intracardiac lead or generator pocket (CIED infection) carries a 1-year mortality of up to 35%.
Genitourinary Prosthetic Devices (T83)
Urinary catheters (indwelling Foley, suprapubic), nephrostomy tubes, ureteral stents, urethral stents, and IUDs are included. Catheter-associated UTI (CAUTI) — when the catheter is documented as the source — maps to T83.511A (infection of indwelling urethral catheter) + organism code. IUD complications include displacement, expulsion, and perforation of uterine wall.
Orthopedic Prosthetic Devices and Implants (T84)
Total joint arthroplasty (hip, knee, shoulder, elbow, ankle) involves replacing articular surfaces with metal (cobalt-chromium, titanium) and polyethylene components. Aseptic loosening results from wear debris causing osteolysis at the bone-implant interface. Periprosthetic joint infection (PJI) occurs via hematogenous seeding or direct inoculation at surgery; biofilm formation on metal surfaces makes eradication extremely difficult. The AAOS PJI clinical practice guidelines define early PJI (<3 months), delayed PJI (3–12 months), and late/hematogenous PJI (>12 months). Internal fixation devices (screws, plates, rods, intramedullary nails) can break or loosen, and periprosthetic fractures around femoral stems represent a growing orthopedic complication.
Other Internal Prosthetic Devices (T85)
Ventricular shunts (ventriculoperitoneal, ventriculoatrial) drain excess CSF in hydrocephalus; malfunction may be proximal (ventricular catheter obstruction by choroid plexus) or distal (peritoneal catheter obstruction). Neurostimulators include spinal cord stimulators (SCS), peripheral nerve stimulators, and deep brain stimulators (DBS); complications include lead migration, generator failure, and infection. Breast implants (saline or silicone) may rupture (intracapsular vs. extracapsular), develop capsular contracture (Baker grades I–IV), or become infected. Peritoneal dialysis catheters are at risk for peritonitis (T85.61xA + organism), the leading cause of catheter loss and technique failure.
💊 Medication Impact / Treatment
Medications directly influence both the development and management of device complications:
Anticoagulants and Antiplatelet Agents
Patients with prosthetic heart valves require life-long anticoagulation (warfarin with target INR 2.5–3.5 for mechanical valves per 2021 AHA/ACC Valve Guidelines). Sub-therapeutic INR increases thrombosis risk (T82.867x); supratherapeutic INR increases hemorrhage risk (T82.817x). Document anticoagulation status, INR, and any medication adjustments.
Antibiotics — Device Infection Treatment
Suppressive antibiotic therapy (chronic oral suppression) for PJI or CIED infection not amenable to explantation. MRSA infections require vancomycin (J3370) or daptomycin (J0878); MSSA may use oxacillin/nafcillin or cefazolin. Antibiotic-impregnated cement spacers (containing tobramycin or vancomycin) are used in two-stage hip/knee exchange for PJI — the local antibiotic delivery is captured by HCPCS L codes. Document specific organisms and sensitivities to support J-code selection.
Immunosuppressants
Transplant recipients, patients on biologic agents (TNF inhibitors, JAK inhibitors), or chronic corticosteroid users are at markedly elevated risk for opportunistic device infections. Document immunosuppressive regimen as a comorbidity; this affects severity documentation and CC/MCC capture.
Anti-Infective Prophylaxis
Perioperative antibiotic prophylaxis (cefazolin) within 60 minutes of incision per CDC SSI prevention guidelines. Patients with joint prostheses: dental prophylaxis per 2015 ADA/AAOS statement (note: no longer universally recommended — individualized decision).
Wound/Local Treatment
Negative pressure wound therapy (NPWT/VAC) may be documented for open wound management following device removal. Captures HCPCS E2402 (NPWT pump) and A6550 (NPWT supply/dressing).
Preview ends here. The full guide continues with FY2026 ICD-10-CM code sets, CPT surgical coding, MS-DRG mapping, reimbursement guidance, CDI query templates, and an audit checklist — all available to CCO Members.
← Back to All Clinical Documentation Guides
🔒 Register or sign in to read the full guide
Unlock the full guide including:
- • 📘 ICD-10-CM Guidelines (FY2026)
- • 🔢 ICD-10-CM Code Set (FY2026)
- • 🔎 Indexing
- • 🏥 CPT (2026)
- • 🧾 HCPCS (2026)
- • 📚 AHA Coding Clinic (Recent Guidance)
- • 💰 HCC / Risk Adjustment (v28)
- • ✍️ CDI Query Templates
- • 🧑⚕️ Treatments (Clinical)
- • 🎓 Patient Education / Summary
